Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Preliminary clinical results with CI-1000

March 18, 1997

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

March 18, 1997

Osiris Therapeutics awarded SBIR grant for tendon regeneration research

March 17, 1997

Genzyme Transgenics and Fresenius to further development of transgenic albumin

March 17, 1997

MGI Pharma and Schein reach marketing agreement for INFeD

March 14, 1997

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

SKB discloses improved antihyperlipidemic agent

March 13, 1997

Advanced-generation matrix HRT patch launched in U.K.

March 12, 1997

Green Cross claims hypolipidemic agents

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...